CRMD NASDAQ
CorMedix Inc.
1W: +5.7%
1M: +1.4%
3M: +11.3%
YTD: -34.2%
1Y: -28.4%
3Y: +153.2%
5Y: +64.3%
$8.00
+0.06 (+0.76%)
Weekly Expected Move ±4.8%
$7
$7
$8
$8
$9
Credit Risk of going bust: higher than 65% of companies Debt: 18.9% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.22 (down 97%), CorMedix Inc. would be worth roughly what it owes.
Total debt $145.2M against a stock market value of $623.6M.
Distance to default 3.84 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $72.6M (short-term plus half of long-term), stock volatility 62.0%; Altman Z'' 4.41. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.22 (down 97%), CorMedix Inc. would be worth roughly what it owes.
Total debt $145.2M against a stock market value of $623.6M.
Distance to default 3.84 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $72.6M (short-term plus half of long-term), stock volatility 62.0%; Altman Z'' 4.41. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
8 relationships7
As Filer
counterparties named
1
As Counterparty
mentioned by others
3
Rel. Types
2025-08-07
Earliest Filing
2025-09-10
Latest Filing
investor: 3
target: 2
partner: 2
Counterparties (Filed by CRMD)
7 relationshipsCompanies named in CRMD's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Melinta Therapeutics, LLC | — | target | Target company in the merger with CorMedix Inc. | 2025-09-02 | View |
| Coriander BidCo LLC | — | partner | Wholly owned subsidiary of CorMedix Inc. used as the merger subsidiary. | 2025-09-02 | View |
| Deerfield Private Design Fund IV, L.P. | — | investor | Representative of Melinta equityholders in the merger agreement. | 2025-09-02 | View |
| Deerfield Private Design Fund III, L.P. | — | investor | Consenting Melinta Member involved in the contingent payment agreement. | 2025-09-02 | View |
| Melinta Therapeutics, LLC | — | target | Target company in the merger agreement to be acquired by CorMedix Inc. | 2025-08-07 | View |
| Coriander BidCo LLC | — | partner | Wholly owned subsidiary of CorMedix Inc. formed to merge with Melinta Therapeutics, LLC. | 2025-08-07 | View |
| Deerfield Private Design Fund IV, L.P. | — | investor | Representative of Melinta equityholders participating in the merger agreement. | 2025-08-07 | View |
Mentioned As Counterparty
1 mentionsOther companies that named CRMD in their SEC 8-K filings.
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-10-19 | Regulation FD; Exhibits | View | |
| 2026-08-13 | Earnings Release; Exhibits | View | |
| 2026-08-07 | Other Events; Exhibits | View | |
| 2026-07-02 | Other Events | View | |
| 2026-07-01 | Accountant Change | View | |
| 2026-06-24 | Shareholder Vote | View | |
| 2026-06-08 | Regulation FD; Exhibits | View | |
| 2026-05-14 | Earnings Release; Exhibits | View | |
| 2026-04-27 | Regulation FD; Exhibits | View | |
| 2026-03-06 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2026-03-05 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2026-01-08 | Results of Operations and Financial Condition; Departure/Election of Directors; Appointment of Offic | View | |
| 2025-11-12 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-10-20 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-09-30 | Financial Statements and Exhibits | View | |
| 2025-09-02 | Entry into Material Definitive Agreement; Completion of Acquisition or Disposition of Assets; Unregi | Agreement Acquisition | View |
| 2025-08-12 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Financial Stateme | Agreement | View |
| 2025-08-07 | Entry into Material Definitive Agreement; Results of Operations and Financial Condition; Unregistere | Agreement | View |
| 2025-06-30 | Other Events; Financial Statements and Exhibits | View | |
| 2025-06-25 | Submission of Matters to a Vote of Security Holders | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR